The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients.

摘要: We prospectively evaluated the efficacy of intravenous iron dextran for replacement stores in deficient hemodialysis patients. Twenty-eight patients with serum ferritin 100 ng/ml 4 months after treatment. Mean hematocrit increased from 29.1 +/- 0.9% at baseline to 33.6 1.8% ten weeks (p ng/ml) was 13 28 2 therapy, 9 6 weeks, and 8 10 weeks. The initial variable most predictive successful therapy. None 15 less than had a > months, compared (61%) ferritins or = ng/ml. Baseline transferrin saturation were not therapeutic success. In summary, this regimen administration resulted improved erythropoiesis, however, study completion remained inadequate majority < highly who failed reach target.